Treatment of pluripotent cells
First Claim
Patent Images
1. A method to expand and differentiate human embryonic stem cells, comprising the steps of:
- a. Culturing human embryonic stem cells, andb. Treating the human embryonic stem cells with an inhibitor of glycogen synthase kinase 3β
(GSK-3B) enzyme activity, wherein the inhibitor is 3-[1-(3-hydroxy-propyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-pyrazin-2-yl-pyrrole-2,5-dione.
3 Assignments
0 Petitions
Accused Products
Abstract
The present invention is provides a method for treating human pluripotent cells. In particular, the methods of the invention are directed to the treatment of human pluripotent cells, whereby the human pluripotent cells can be efficiently expanded in culture and differentiated by treating the pluripotent cells with an inhibitor of glycogen synthase kinase 3β (GSK-3B) enzyme activity.
-
Citations
9 Claims
-
1. A method to expand and differentiate human embryonic stem cells, comprising the steps of:
-
a. Culturing human embryonic stem cells, and b. Treating the human embryonic stem cells with an inhibitor of glycogen synthase kinase 3β
(GSK-3B) enzyme activity, wherein the inhibitor is 3-[1-(3-hydroxy-propyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-4-pyrazin-2-yl-pyrrole-2,5-dione. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
Specification